Previous studies have explored the dysregulation of NUPR1 in numerous malignant tumors, such as brain tumors, lung cancer, breast cancer, colorectal cancer, and prostate cancer.41, 42, 43. This evidence concerns the gene NUPR1 and prostate cancer.